
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
USHG Acquisition Corp | NYSE:HUGS | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.05 | 0 | 00:00:00 |
☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware |
001-40109 |
85-4281417 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) | ||
853 Broadway, 17th Floor New York, New York |
10010 | |||
(Address of principal executive offices) |
(Zip Code) |
Title of Each Class: |
Trading Symbol(s) |
Name of Each Exchange on Which Registered: | ||
Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant |
HUGSU |
New York Stock Exchange | ||
Class A common stock, par value $0.0001 per share |
HUGS |
New York Stock Exchange | ||
Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share |
HUGSW |
New York Stock Exchange |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Auditor PCAOB ID Number: |
Auditor Name: |
Auditor Location: | ||
100 |
WithumSmith + Brown, PC |
New York, New York, United States of America |
PART I |
||||||
Item 1. |
4 |
|||||
Item 1A. |
25 |
|||||
Item 1B. |
25 |
|||||
Item 2. |
25 |
|||||
Item 3. |
25 |
|||||
Item 4. |
25 |
|||||
PART II |
||||||
Item 5. |
25 |
|||||
Item 6. |
26 |
|||||
Item 7. |
26 |
|||||
Item 7A. |
32 |
|||||
Item 8. |
33 |
|||||
Item 9. |
33 |
|||||
Item 9A. |
33 |
|||||
Item 9B. |
34 |
|||||
PART III |
||||||
Item 10. |
34 |
|||||
Item 11. |
43 |
|||||
Item 12. |
44 |
|||||
Item 13. |
46 |
|||||
Item 14. |
47 |
|||||
PART IV |
||||||
Item 15. |
48 |
|||||
Item 16. |
50 |
• |
“amended and restated certificate of incorporation” are to the second amended and restated certificate of incorporation that the Company adopted prior to the consummation of our initial public offering (the “Initial Public Offering”); |
• |
“Board” are to our board of directors; |
• |
“common stock” are to our Class A common stock and our Class B common stock, collectively; |
• |
“DGCL” are to the Delaware General Corporation Law as the same may be amended from time to time; |
• |
“Founder Shares” are to shares of our Class B common stock initially issued to our Sponsor in a private placement prior to the Initial Public Offering, including those shares subsequently contributed by our Sponsor to Share Our Strength, the additional 253,000 shares of Class B common stock that may be issued prior to or in connection with our initial Business Combination (as defined below) (the “Discretionary Allocation Shares”) and the shares of our Class A common stock that will be issued upon the automatic conversion of the Class B common stock at the time of our initial Business Combination (for the avoidance of doubt, such shares of our Class A common stock will not be “public shares”); |
• | “management” or our “management team” are to our executive officers and directors (including our director nominees who will become directors in connection with the consummation of the Initial Public Offering); |
• | “public shares” are to shares of our Class A common stock sold as part of the units in the Initial Public Offering (whether they were purchased in the Initial Public Offering or thereafter in the open market); |
• | “public stockholders” are to the holders of our public shares, including our Sponsor and management team to the extent our Sponsor and/or members of our management team purchase public shares, provided that our Sponsor’s and each member of our management team’s status as a “public stockholder” will only exist with respect to such public shares; |
• | “public warrants” are to our warrants sold as part of the units in the Initial Public Offering (whether they were purchased in the Initial Public Offering or thereafter in the open market) and to any Private Placement Warrants (as defined below) or warrants issued upon conversion of working capital loans that are sold to third parties that are not initial purchasers or officers or directors (or permitted transferees) following the consummation of our initial Business Combination; |
• | “Sponsor” are to USHG Investments, LLC, a Delaware limited liability company; |
• | “USHG” are to Union Square Hospitality Group, LLC, an affiliate of our Sponsor; and |
• | “we,” “us,” “our,” the “Company” or “our company” are to USHG Acquisition Corp., a Delaware corporation. |
• | our ability to select an appropriate target business or businesses; |
• | our ability to complete our initial Business Combination; |
• | our expectations around the performance of a prospective target business or businesses; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial Business Combination; |
• | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial Business Combination; |
• | our potential ability to obtain additional financing to complete our initial Business Combination; |
• | our pool of prospective target businesses; |
• | our ability to consummate an initial Business Combination due to the uncertainty resulting from the COVID-19 pandemic; |
• | the ability of our officers and directors to generate a number of potential Business Combination opportunities; |
• | our public securities’ potential liquidity and trading; |
• | the lack of a market for our securities; |
• | the use of proceeds not held in the Trust Account (as defined below) or available to us from interest income on the Trust Account balance; |
• | the Trust Account not being subject to claims of third parties; or |
• | our financial performance following the Initial Public Offering. |
Item 1. |
Business |
• | Unique Culture of “ Enlightened Hospitality ” |
• | Enlightened Hospitality can enable organizations to attract and retain the best talent, by taking care of team members first, and creating a unifying purpose to company culture. |
• | Enlightened Hospitality can drive deep and emotional connections with customers, resulting in long- term brand value. |
• | Enlightened Hospitality can lead to responsible growth by being mindful of a brand’s obligations towards all stakeholders, while creating long-term shareholder value. |
• | Building Category Disruptive Brands direct-to-consumer |
• | Scaling & Expanding Rapidly: |
brands. USHG has created 30 brands, including Shake Shack, which began as a humble hot dog cart in Madison Square Park in 2004, and has now grown to become a publicly traded company with over 300 locations across 15 countries. USHG’s catering and events, venue management and consulting business operates at the premium end of its industries and has expanded in recent years to become a national brand. We believe USHG’s track record of growth and innovation will make the strong ties of several members of our management team to USHG a valuable resource for us. |
• | Deep Relevance of Enlightened Hospitality |
• | Blue- Chip Reputation and Broad Public & Private Company Experience |
• | Notable Operating & Investing Track Record e-Commerce and technology sectors. Their experience will provide us deep cross-functional expertise in branding, marketing, technology, real estate, organizational culture, and leadership development. By deploying these capabilities, our management team will be well-positioned to amplify the growth of companies within their platforms. |
• | Differentiated Access to Investment Opportunities |
• | Has a Distinct People-First Culture that Aligns with Our Core Values |
• | Has a Superior Leadership Team with a Clear Vision and Strategy |
• | Is Growth-Oriented and Scalable with a Large, Addressable Market Opportunity |
• | Is Positioned at a Key Inflection Point of its Growth Trajectory |
• | subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial Business Combination; and |
• | cause us to depend on the marketing and sale of a single product or limited number of products or services. |
Type of Transaction |
Whether Stockholder Approval is Required |
|||
Purchase of assets |
No | |||
Purchase of stock of target not involving merger with the company |
No | |||
Merger of target into a subsidiary of the company |
No | |||
Merger of the company with a target |
Yes |
• | We issue shares of common stock that will be equal to or in excess of 20% of the number of our shares of common stock then-outstanding (other than in a public offering); |
• | Any of our directors, officers or substantial security holder (as defined by the NYSE rules) has a 5% or greater interest, directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of common stock could result in an increase in issued and outstanding common stock or voting power of 1% or more (or 5% or more if the related party involved is classified as such solely because such person is a substantial security holder); or |
• | The issuance or potential issuance of common stock will result in our undergoing a change of control. |
• | the timing of the transaction, including in the event we determine stockholder approval would require additional time and there is either not enough time to seek stockholder approval or doing so would place the company at a disadvantage in the transaction or result in other additional burdens on the company; |
• | the expected cost of holding a stockholder vote; |
• | the risk that the stockholders would fail to approve the proposed Business Combination; |
• | other time and budget constraints of the company; and |
• | additional legal complexities of a proposed Business Combination that would be time-consuming and burdensome to present to stockholders. |
Item 1A. |
Risk Factors |
Item 1B. |
Unresolved Staff Comments |
Item 2. |
Properties |
Item 3. |
Legal Proceedings |
Item 4. |
Mine Safety Disclosures |
Item 5. |
Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities |
Item 6. |
Selected Financial Data |
Item 7. |
Management’s Discussion And Analysis Of Financial Condition And Results Of Operations |
Gross proceeds |
$ | 287,500,000 | ||
Less: |
||||
Deferred underwriting fees and other offering costs |
(15,887,831 | ) | ||
Proceeds allocated to public warrants |
(13,129,167 | ) | ||
Plus: |
||||
Total accretion of carrying value to redemption value |
29,016,998 | |||
|
|
|||
Class A common stock subject to possible redemption |
$ |
287,500,000 |
||
|
|
Item 7A. |
Quantitative and Qualitative Disclosures about Market Risk |
Item 8. |
Financial Statements and Supplementary Data |
Item 9. |
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. |
Item 9A. |
Controls and Procedures. |
Item 9B. |
Other Information |
Item 10. |
Directors, Executive Officers and Corporate Governance |
Name |
Age |
Position | ||
Danny Meyer | 63 | Chairman | ||
Adam D. Sokoloff | 59 | Chief Executive Officer and Director | ||
Tiffany F. Daniele | 39 | Chief Financial Officer | ||
J. Kristofer Galashan | 43 | Director | ||
Lisa Skeete Tatum | 54 | Director | ||
Mark Leavitt | 63 | Director | ||
Walter Robb | 68 | Director | ||
Randy Garutti | 46 | Director | ||
Heidi Messer | 52 | Director | ||
Robert K. Steel | 70 | Director |
• | meeting with our independent registered public accounting firm regarding, among other issues, audits, and adequacy of our accounting and control systems; |
• | monitoring the independence of the independent registered public accounting firm; |
• | verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; |
• | inquiring and discussing with management our compliance with applicable laws and regulations; |
• | pre-approving all audit services and permitted non-audit services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed; |
• | appointing or replacing the independent registered public accounting firm; |
• | determining the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work; |
• | establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; |
• | monitoring compliance on a quarterly basis with the terms of the Initial Public Offering and, if any noncompliance is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing compliance with the terms of the Initial Public Offering; and |
• | reviewing and approving all payments made to our existing stockholders, executive officers or directors and their respective affiliates. Any payments made to members of our audit committee will be reviewed and approved by our Board, with the interested director or directors abstaining from such review and approval. |
• | should have demonstrated notable or significant achievements in business, education or public service; |
• | should possess the requisite intelligence, education and experience to make a significant contribution to the Board and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and |
• | should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the stockholders. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation; |
• | reviewing and approving the compensation of all of our other Section 16 executive officers; |
• | reviewing our executive compensation policies and plans; |
• | implementing and administering our incentive compensation equity-based remuneration plans; |
• | assisting management in complying with our proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees; |
• | producing a report on executive compensation to be included in our annual proxy statement; and |
• | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
Item 11. |
Executive Compensation |
Item 12. |
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
• | each person known by us to be the beneficial owner of more than 5% of our issued and outstanding shares of common stock; |
• | each of our executive officers and directors; and |
• | all our executive officers and directors as a group. |
* | less than 1% |
(1) | Unless otherwise noted, the business address of each of our stockholders is 853 Broadway, 17th Floor, New York, NY 10003. |
(2) | Interests shown consist solely of Founder Shares, classified as Class B common stock. Such shares will automatically convert into Class A common stock at the time of our initial Business Combination as described in the section entitled “Description of Securities.” |
(3) | According to the Schedule 13G/A filed on February 10, 2022. M.H. Davidson & Co. (“CO”) has shared voting and dispositive power over 54,695 shares of HUGS Class A Stock. Davidson Kempner Partners (“DKP”) has shared voting and dispositive power over 341,792 shares of HUGS Class A Stock. Davidson Kempner Institutional Partners, L.P. (“DKIP”) has shared voting and dispositive power over shares of HUGS Class A Stock. Davidson Kempner International, Ltd. (“DKIL”) has shared voting and dispositive power over 819,445 shares of HUGS Class A Stock. Davidson Kempner Capital Management LP (“DKCM”) has shared voting and dispositive power over 1,946,426 shares of HUGS Class A Stock. Anthony A. Yoseloff (“Mr. Yoseloff”) has shared voting and dispositive power over 1,946,426 shares of HUGS Class A Stock. M.H. Davidson & Co. GP, L.L.C., a Delaware limited liability company, is the general partner of CO. DKCM, a registered investment adviser with the SEC, acts as investment manager to each of CO, DKP, DKIP and DKIL either directly or by virtue of a sub-advisory agreement with the investment manager of the relevant fund. DKCM GP LLC, a Delaware limited liability company, is the general partner of DKCM. The managing members of DKCM are Mr. Yoseloff, Eric P. Epstein, Conor Bastable, Shulamit Leviant, Morgan P. Blackwell, Patrick W. Dennis, Gabriel T. Schwartz, Zachary Z. Altschuler, Joshua D. Morris and Suzanne K. Gibbons. Mr. Yoseloff, through DKCM, is responsible for the voting and investment decisions relating to the securities held by CO, DKP, DKIP and DKIL. The address of the principal business office of each of the foregoing persons is c/o Davidson Kempner Capital Management LP, 520 Madison Avenue, 30th Floor, New York, New York 10022. |
(4) | The shares reported above are held in the name of our Sponsor. Our Sponsor is controlled by USHG. Certain of our directors, officers and their affiliates hold membership interests in our Sponsor. |
Item 13. |
Certain Relationships and Related Transactions, and Director Independence |
Item 14. |
Principal Accountant Fees and Services. |
(a) | The following is a summary of fees paid or to be paid to WithumSmith+Brown, PC (“Withum”) for services rendered. |
(b) |
Audit Fees year-end financial statements and services that are normally provided by Withum in connection with regulatory filings. The aggregate fees of Withum related to audit and review services in connection with our Initial Public Offering and regulatory filings totaled approximately $105,495 for the year ended December 31, 2021. |
(c) |
Audit-Related Fees Audit Fees |
(d) |
Tax Fees |
(e) |
All Other Fees |
Item 15. |
Exhibits, Financial Statements and Financial Statement Schedules |
(f) | The following documents are filed as part of this Form 10-K: |
(1) | Financial Statements |
(2) | Financial Statements Schedule |
(3) | Exhibits |
* | Filed herewith |
** | Furnished herewith |
(1) | Incorporated by reference to the Company’s Form 8-K, filed with the SEC on March 1, 2021. |
(2) | Incorporated by reference to the Company’s Form S-1, as amended, initially filed with the SEC on February 5, 2021. |
(3) | Incorporated by reference to the Company’s Form 8-K, filed with the SEC on November 9, 2021. |
Item 16. |
Form 10-K Summary |
March 14, 2022 | USHG Acquisition Corp. | |||||
By: | /s/ Adam Sokoloff | |||||
Name: | Adam Sokoloff | |||||
Title: | Chief Executive Officer | |||||
(Principal Executive Officer) |
Name |
Position |
Date | ||
/s/ Daniel H. Meyer |
Chairman | March 14, 2022 | ||
Daniel H. Meyer | ||||
/s/ Adam D. Sokoloff Adam D. Sokoloff |
Chief Executive Officer and Director | March 14, 2022 | ||
(Principal Executive Officer) |
||||
/s/ Tiffany F. Daniele |
Chief Financial Officer | March 14, 2022 | ||
Tiffany F. Daniele | (Principal Financial and Accounting Officer) |
|||
/s/ J. Kristofer Galashan |
Director | March 14, 2022 | ||
J. Kristofer Galashan | ||||
/s/ Randy Garutti |
Director | March 14, 2022 | ||
Randy Garutti | ||||
/s/ Mark Leavitt |
Director | March 14, 2022 | ||
Mark Leavitt | ||||
/s/ Heidi Messer |
Director | March 14, 2022 | ||
Heidi Messer | ||||
/s/ Walter Robb |
Director | March 14, 2022 | ||
Walter Robb | ||||
/s/ Robert K. Steel |
Director | March 14, 2022 | ||
Robert K. Steel | ||||
/s/ Lisa Skeete Tatum |
Director | March 14, 2022 | ||
Lisa Skeete Tatum |
December 31, 2021 |
December 31, 2020 |
|||||||
ASSETS |
||||||||
Cash |
$ | 386,462 | $ | 24,120 | ||||
Deferred offering costs associated with proposed public offering |
— | 255,000 | ||||||
Prepaid expenses |
459,422 | — | ||||||
Total current assets |
845,884 | 279,120 | ||||||
Marketable securities held in trust account |
287,516,155 | — | ||||||
Other assets |
73,219 | — | ||||||
Total assets |
$ |
288,435,258 |
$ |
279,120 |
||||
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 33,955 | $ | — | ||||
Franchise tax payable |
200,000 | — | ||||||
Accrued expenses |
28,999 | 265,000 | ||||||
Total current liabilities |
262,954 | 265,000 | ||||||
Warrant liabilities |
19,374,577 | — | ||||||
Deferred underwriting compensation |
15,812,500 | — | ||||||
Deferred legal fees |
1,311,703 | — | ||||||
Total liabilities |
36,761,734 | 265,000 | ||||||
Commitments and Contingencies |
||||||||
Common stock subject to possible redemption, 28,750,000 shares at $10.00 redemption value |
287,500,000 | — | ||||||
Stockholders’ Equity (Deficit): |
||||||||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding |
— | — | ||||||
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; none or (excluding 28,750,000 and no shares subject to possible redemption), as of December 31, 2021 and December 31, 2020, respectively |
— | — | ||||||
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,934,500 shares issued and outstanding |
693 | 693 | ||||||
Additional paid-in capital |
— | 23,427 | ||||||
Accumulated deficit |
(35,827,169 | ) | (10,000 | ) | ||||
Total stockholders’ (deficit) equity |
(35,826,476 | ) | 14,120 | |||||
Total Liabilities and Stockholders’ (Deficit) Equity |
$ |
288,435,258 |
$ |
279,120 |
||||
For The Year Ended December 31, 2021 |
For The Period From December 4, 2020 (Inception) Through December 31, 2020 |
|||||||
Formation and operating costs |
$ | 1,636,359 | $ | 10,000 | ||||
Franchise tax expense |
200,000 | — | ||||||
Loss from operations |
(1,836,359 |
) |
(10,000 |
) | ||||
Other Income (Expense): |
||||||||
Change in fair value of warrant liabilities |
(4,392,077 | ) | — | |||||
Offering costs allocated to derivative warrant liabilities |
(757,984 | ) | — | |||||
Interest on marketable securities |
16,155 | — | ||||||
Net loss |
$ |
(6,970,265 |
) |
$ |
(10,000 |
) | ||
Weighted average shares outstanding of Class A common stock, basic and diluted |
24,102,740 | — | ||||||
Basic and diluted net income per share of Class A common stock |
$ |
(0.22 |
) |
$ |
(0.00 |
) | ||
Weighted average shares outstanding of Class B common stock, basic and diluted |
6,934,500 | 6,934,500 | ||||||
Basic and diluted net income per share of Class B common stock |
$ |
(0.22 |
) |
$ |
(0.00 |
) | ||
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Total Stockholders’ Equity (Deficit) |
|||||||||||||||||
Class B |
||||||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
Balance as of January 1, 2021 |
6,934,500 |
$ |
693 |
$ |
23,427 |
$ |
(10,000 |
) |
$ |
14,120 |
||||||||||
Excess cash received over fair value of Private Placement Warrants |
— | — | 146,667 | — | 146,667 | |||||||||||||||
Accretion of Class A Common Stock to redemption value |
— | — | (170,094 | ) | (28,846,905 | ) | (29,016,998 | ) | ||||||||||||
Net loss |
— | — | — | (6,970,265 | ) | (6,970,265 | ) | |||||||||||||
Balance as of December 31, 2021 |
6,934,500 |
$ |
693 |
$ |
— |
$ |
(35,827,169 |
) |
$ |
(35,826,476 |
) | |||||||||
Common Stock |
Additional Paid-In Capital |
Accumulated Deficit |
Total Stockholders’ Equity |
|||||||||||||||||
Class B |
||||||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
Balance as of December 4, 2020 (Inception) |
— |
$ |
$ |
— |
$ |
— |
$ |
— |
||||||||||||
Issuance of common stock to Sponsor |
6,934,500 | 693 | 23,427 | — | 24,120 | |||||||||||||||
Net loss |
— | — | — | (10,000 | ) | (10,000 | ) | |||||||||||||
Balance as of December 31, 2020 |
6,934,500 |
$ |
693 |
$ |
23,427 |
$ |
(10,000 |
) |
$ |
14,120 |
||||||||||
For The Year Ended December 31, 2021 |
For The Period From December 4, 2020 (Inception) Through December 31, 2020 |
|||||||
Cash Flows from Operating Activities |
||||||||
Net loss |
$ | (6,970,265 | ) | $ | (10,000 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities |
||||||||
Change in fair value of warrant liabilities |
4,392,077 | — | ||||||
Offering costs allocated to derivative warrant liabilities |
757,984 | — | ||||||
Interest earned on marketable securities in Trust Accoun t |
(16,155 | ) | — | |||||
Changes in operating assets and liabilities |
||||||||
Prepaid expenses |
(459,422 | ) | — | |||||
Other assets |
(73,219 | ) | — | |||||
Accounts payable |
33,955 | — | ||||||
Franchise tax payable |
200,000 | — | ||||||
Accrued expenses |
18,999 | 10,000 | ||||||
Deferred legal fees |
697,995 | — | ||||||
|
|
|
|
|||||
Net cash used by operating activities |
(1,418,051 | ) | — | |||||
|
|
|
|
|||||
Cash Flows from Investing Activities |
||||||||
Cash deposited in Trust Account |
(287,500,000 | ) | — | |||||
|
|
|
|
|||||
Net cash used in investing activities |
(287,500,000 | ) | — | |||||
|
|
|
|
|||||
Cash Flows from Financing Activities |
||||||||
Proceeds from issuance of Class B common stock to Sponsor |
— | 24,120 | ||||||
Proceeds from issuance of Class A common stock and warrants |
289,500,000 | — | ||||||
Proceeds from note payable and advances from related party |
334,000 | — | ||||||
Repayment of note payable and advances from related party |
(334,000 | ) | — | |||||
Payment of offering costs |
(219,607 | ) | — | |||||
|
|
|
|
|||||
Net cash provided by financing activities |
289,280,393 | 24,120 | ||||||
|
|
|
|
|||||
Net increase in cash |
362,342 | — | ||||||
Cash—beginning of period |
24,120 | 24,120 | ||||||
|
|
|
|
|||||
Cash—end of period |
$ | 386,462 | $ | 24,120 | ||||
|
|
|
|
|||||
Supplemental disclosure of noncash investing and financing activities: |
||||||||
Deferred legal fees related to Initial Public Offering |
$ | 613,708 | $ | — | ||||
|
|
|
|
|||||
Deferred underwriting compensation |
$ | 15,812,500 | $ | — | ||||
|
|
|
|
|||||
Deferred offering costs included in accrued expenses |
$ | — | $ | 255,000 | ||||
|
|
|
|
|||||
Deferred offering costs paid through prepaid legal expense funded by sponsor |
$ | — | $ | 24,120 | ||||
|
|
|
|
Gross proceeds |
$ | 287,500,000 | ||
Less: |
||||
Deferred underwriting fees and other offering costs |
(15,887,831 | ) | ||
Proceeds allocated to public warrants |
(13,129,167 | ) | ||
Plus: |
||||
Total accretion of carrying value to redemption value |
29,016,998 | |||
Class A common stock subject to possible redemption |
$ |
287,500,000 |
||
• | Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
For The Year Ended December 31, 2021 |
For The Period from December 04, 2020 (Inception) through December 31, 2020 |
|||||||
Redeemable Class A Common Stock |
||||||||
Numerator: Net loss allocable to Redeemable Class A Common Stock |
$ | (5,412,932 | ) | $ | — | |||
Denominator: Weighted Average Share Outstanding, Redeemable Class A Common Stock |
||||||||
Basic and diluted weighted average shares outstanding, Redeemable Class A |
24,102,740 | — | ||||||
Basic and diluted net earnings per share, Redeemable Class A |
$ | (0.22 | ) | $ | (0.00 | ) | ||
Non-Redeemable Class B Common Stock |
||||||||
Numerator: Net loss allocable to non-redeemable Class B Common Stock |
||||||||
Net loss allocable to non-redeemable Class B Common Stock |
$ | (1,557,333 | ) | $ | (10,000 | ) | ||
Denominator: Weighted Average Non-Redeemable Class B Common Stock |
6,934,500 | 6,934,500 | ||||||
Basic and diluted weighted average shares outstanding, Non-Redeemable Class B |
$ | (0.22 | ) | $ | (0.00 | ) | ||
Year Ended December 31, 2021 |
Year Ended December 31, 2020 |
|||||||
Federal |
||||||||
Current |
$ | — | $ | — | ||||
Deferred |
(265,962 | ) | (2,100 | ) | ||||
State and Local |
||||||||
Current |
$ | — | $ | — | ||||
Deferred |
— | — | ||||||
Change in valuation allowance |
265,962 | 2,100 | ||||||
Income tax provision |
$ | — | $ | — | ||||
Year Ended December 31, 2021 |
Year Ended December 31, 2020 |
|||||||
Deferred tax asset |
||||||||
Net Operating Loss Carryforward |
$ | 265,962 | $ | 2,100 | ||||
Total deferred tax assets |
265,962 | 2,100 | ||||||
Valuation allowance |
(265,962 | ) | (2,100 | ) | ||||
Deferred tax asset, net of allowance |
$ | — | $ | — | ||||
Year Ended December 31, 2021 |
Year Ended December 31, 2020 |
|||||||
Statutory federal income tax rate |
21.00 | % | 21.00 | % | ||||
State taxes, net of federal tax benefit |
— | % | — | % | ||||
Change in fair value of derivative liabilities |
(13.23 | %) | — | % | ||||
Transaction costs allocated to warrant issuance |
(3.95 | %) | — | % | ||||
Change in valuation allowance |
(3.82 | %) | (21.00 | %) | ||||
Income tax provision |
— | % | — | % | ||||
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price (the “closing price”) of shares of Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares of Class A common stock to be determined by reference to an agreed table based on the redemption date and the “fair market value” of shares of Class A common stock; |
• | if, and only if, the last reported sale price of Class A common stock equals or exceeds $10.00 per share (as adjusted) on the trading day prior to the date on which of redemption is sent to the warrant holders. |
Held-To-Maturity |
Level |
Fair Value |
||||||
U.S. Treasury Marketable securities held in Trust Account—U.S. Treasury Securities Money Market Fund |
1 | $ | 287,516,155 | |||||
|
|
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Warrant liabilities: |
|
|||||||||||||||
Public Warrants |
$ | 15,909,292 | $ | — | $ | — | $ | 15,909,292 | ||||||||
Private Placement Warrants |
— | — | 3,465,285 | 3,465,285 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total warrant liabilities |
$ | 15,909,292 | $ | — | $ | 3,465,285 | $ | 19,374,577 | ||||||||
|
|
|
|
|
|
|
|
As of December 31, 2021 |
||||
Exercise price |
$ | 11.50 | ||
IPO price |
$ | 10.00 | ||
Underlying asset price (per share) |
$ | 10.37 | ||
Volatility |
32.25 | % | ||
Time to Maturity (Years) |
5.50 | |||
Risk-free rate |
1.31 | % | ||
Dividend yield |
0.00 | % |
Public Warrant Liability |
Private Warrant Liability |
Total |
||||||||||
Fair value, March 01, 2021 |
$ | 13,129,167 | $ | 1,853,333 | $ | 14,982,500 | ||||||
Recognized loss on change in fair value |
(2,780,125 | ) | (1,611,952 | ) | (4,392,077 | ) | ||||||
|
|
|
|
|
|
|||||||
Fair value, December 31, 2021 |
$ | 15,909,292 | $ | 3,465,285 | $ | 19,374,577 | ||||||
|
|
|
|
|
|
1 Year USHG Acquisition Chart |
1 Month USHG Acquisition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions